Extract from the Register of European Patents

EP Citations: EP1306088

Cited inSearch
Type:Patent literature
Publication No.:EP0400835  [X]
 (MERCK & CO INC [US]) [X] 1-20 * page 1 - page 11, line 15 * * page 26, lines 21-49 * * page 37, lines 40-42; claim -; table I *;
Type:Patent literature
Publication No.:JPH0327362  [D]
 (MERCK & CO INC);
Type:Patent literature
Publication No.:EP0459136  [DY]
 (TAKEDA CHEMICAL INDUSTRIES LTD [JP]) [DY] 1-20 * claim - *;
Type:Patent literature
Publication No.:EP0501892  [Y]
 (SANOFI ELF [FR]) [Y] 1-20 * page 9, lines 28-30; claim - *;
Type:Patent literature
Publication No.:JPH05132467  [D]
 (SANOFI ELF);
Type:Patent literature
Publication No.:GB2270841  [PY]
 (MERCK & CO INC [US]) [PY] 1-20 * the whole document, especially page 4, compound IX *;
Type:Non-patent literature
Publication information:[Y]  - K. KINUGAWA, "Effects of a nonpeptide angiotensin II receptor antagonist (CV-11974) on [Ca2+]i and cell motion in cultured ventricular myocites.", EUR. J. PHARMACOL., (199304), vol. 235, no. 2-3, pages 313- - 316, XP008014593 [Y] 1-20 * the whole document *
DOI: http://dx.doi.org/10.1016/0014-2999(93)90153-9
Type:Non-patent literature
Publication information:[T]  - T.WADA ET AL., "Combined Effects of the Angiotensin II Antagonist Candesartan Cilexetil (TCV-116) and Other Classes of Antihypertensive Drugs in Spontaneously Hypertensive Rats", HYPERTENS. RES., (199612), vol. 19, no. 4, pages 247 - 254, XP001031392 [T] 1-20 * the whole document *
Type:Non-patent literature
Publication information:[A]  - T. NAGAO ET AL., "Calcium Entry Blockers: Antihypertensive and Natriuretic Effects in Experimental Animals", AM. J. CARDIOL., (19851206), vol. 56, no. 16, pages 56H - 61H, XP008014594 [A] 1-20 * the whole document *
DOI: http://dx.doi.org/10.1016/0002-9149(85)90545-4
Type:Non-patent literature
Publication information:[XP]  - Y. INADA ET AL., "Antihypertensive Effects of a Highly Potent and long-Acting Angiotensin II Subtype-1 Receptor Antagonist. (+-)-1-(Cyclohexyloxycarbonyloxy)ethyl w2-Ethoxy-1-[[2'-(1H-Tetrazol-5-yl)Biphenyl-4-yl]Methyl]-1H-Benzimidazole-7-Carboxylate (TCV-116), in Various Hypertensive Rats", J. PHARM. EXP THER., (199403), vol. 268, no. 3, pages 1540 - 1547, XP008014592 [XP] 1-20 * the whole document *
Type:Non-patent literature
Publication information:[T]  - K. SATO ET AL., "ROLE OF ANGIOTENSIN II IN REFLEX TACHYCARDIA DURING HYPOTENSION CAUSED BY A CALCIUM CHANNEL BLOCKER", CLIN. AND EXPER. HYPERTENSION, (199607), vol. 18, no. 5, pages 607 - 624, XP001031405 [T] 1-20 * the whole document *
Type:Non-patent literature
Publication information:[A]  - P SLEIGHT, "Cardiac Benefits of ACE Inhibitors and Calcium Antagonists Alone and in Combination", J. CARDIOVASC. PHARMACOL., (1994), vol. 23, no. Suppl. 1, pages S39 - S42, XP001031381 [A] 1-20 * abstract *
Cited inExamination
Type:Patent literature
Publication No.:EP0461039  
Type:Patent literature
Publication No.:WO9210097  
Type:Patent literature
Publication No.:EP0520423  
Type:Patent literature
Publication No.:EP0533058  
Type:Patent literature
Publication No.:EP0546358  
Type:Patent literature
Publication No.:WO9409778  
Type:Non-patent literature
Publication information:   - FUMIHIKO OKADA, "Depression after treatment with thiazide diuretics for hypertension", AM. J. PSYCHIATRY, (1985), vol. 142, no. 9, pages 1101 - 1102, XP008037312
Type:Non-patent literature
Publication information:   - GRIFFING G. T. ET AL., "Reversal of diuretic-induced secondary hyperaldosteronism and hypeokalemia by Enalapril: a new angiotensin-converting enzyme inhibitor", METABOLISM, (1983), vol. 32, no. 7, pages 711 - 716, XP008037313
Type:Non-patent literature
Publication information:   - PECZON J. D. ET AL., "Diuretic drugs in glaucoma", AM. J. OPHTHALM., (1968), vol. 66, no. 4, pages 680 - 683, XP002067602